Return On Assets in % of Skye Bioscience, Inc. from 2013 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Skye Bioscience, Inc. quarterly/annual Return On Assets history and change rate from 2013 to Q3 2025.
  • Skye Bioscience, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -88.7 %, a 188% decline year-over-year.
  • Skye Bioscience, Inc. annual Return On Assets for 2024 was -31.6 %, a 92.8% increase from 2023.
  • Skye Bioscience, Inc. annual Return On Assets for 2023 was -438 %, a 35.8% decline from 2022.
  • Skye Bioscience, Inc. annual Return On Assets for 2022 was -323 %, a 207% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Skye Bioscience, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -88.7 -57.9 -188% 01 Jul 2025 30 Sep 2025
Q2 2025 -62.5 +18.2 +22.6% 01 Apr 2025 30 Jun 2025
Q1 2025 -42.6 +77.7 +64.6% 01 Jan 2025 31 Mar 2025
Q4 2024 -31.6 +407 +92.8% 01 Oct 2024 31 Dec 2024
Q3 2024 -30.8 +516 +94.4% 01 Jul 2024 30 Sep 2024
Q2 2024 -80.7 +372 +82.2% 01 Apr 2024 30 Jun 2024
Q1 2024 -120 +281 +70% 01 Jan 2024 31 Mar 2024
Q4 2023 -438 -116 -35.8% 01 Oct 2023 31 Dec 2023
Q3 2023 -547 -352 -181% 01 Jul 2023 30 Sep 2023
Q2 2023 -453 -325 -254% 01 Apr 2023 30 Jun 2023
Q1 2023 -401 -291 -265% 01 Jan 2023 31 Mar 2023
Q4 2022 -323 -217 -207% 01 Oct 2022 31 Dec 2022
Q3 2022 -194 -75.4 -63.3% 01 Jul 2022 30 Sep 2022
Q2 2022 -128 +27.9 +17.9% 01 Apr 2022 30 Jun 2022
Q1 2022 -110 +91.9 +45.5% 01 Jan 2022 31 Mar 2022
Q4 2021 -105 +226 +68.3% 01 Oct 2021 31 Dec 2021
Q3 2021 -119 -108 -944% 01 Jul 2021 30 Sep 2021
Q2 2021 -156 +176 +53.1% 01 Apr 2021 30 Jun 2021
Q1 2021 -202 -923 -128% 01 Jan 2021 31 Mar 2021
Q4 2020 -331 -368 -1008% 01 Oct 2020 31 Dec 2020
Q3 2020 -11.4 +338 +96.7% 01 Jul 2020 30 Sep 2020
Q2 2020 -332 -69.3 -26.3% 01 Apr 2020 30 Jun 2020
Q1 2020 722 +1.76K 01 Jan 2020 31 Mar 2020
Q4 2019 36.5 +959 01 Oct 2019 31 Dec 2019
Q3 2019 -349 +437 +55.6% 01 Jul 2019 30 Sep 2019
Q2 2019 -263 +523 +66.5% 01 Apr 2019 30 Jun 2019
Q1 2019 -1.04K -159 -18% 01 Jan 2019 31 Mar 2019
Q4 2018 -922 -304 -49.2% 01 Oct 2018 31 Dec 2018
Q3 2018 -786 +25.8 +3.18% 01 Jul 2018 30 Sep 2018
Q2 2018 -786 -20.2 -2.63% 01 Apr 2018 30 Jun 2018
Q1 2018 -883 -474 -116% 01 Jan 2018 31 Mar 2018
Q4 2017 -618 -332 -116% 01 Oct 2017 31 Dec 2017
Q3 2017 -812 -668 -463% 01 Jul 2017 30 Sep 2017
Q2 2017 -766 -662 -636% 01 Apr 2017 30 Jun 2017
Q1 2017 -409 -209 -104% 01 Jan 2017 31 Mar 2017
Q4 2016 -286 -78.6 -37.9% 01 Oct 2016 31 Dec 2016
Q3 2016 -144 +235 +62% 01 Jul 2016 30 Sep 2016
Q2 2016 -104 +696 +87% 01 Apr 2016 30 Jun 2016
Q1 2016 -200 +485 +70.8% 01 Jan 2016 31 Mar 2016
Q4 2015 -207 +413 +66.6% 01 Oct 2015 31 Dec 2015
Q3 2015 -379 -115 -43.5% 01 Jul 2015 30 Sep 2015
Q2 2015 -800 -662 -478% 01 Apr 2015 30 Jun 2015
Q1 2015 -685 -642 -1509% 01 Jan 2015 31 Mar 2015
Q4 2014 -620 -2.11K 01 Oct 2014 31 Dec 2014
Q3 2014 -264 01 Jul 2014 30 Sep 2014
Q2 2014 -138 01 Apr 2014 30 Jun 2014
Q1 2014 -42.6 01 Jan 2014 31 Mar 2014
Q4 2013 1.49K* 01 Nov 2013 31 Jan 2014

Skye Bioscience, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -31.6 +407 +92.8% 01 Jan 2024 31 Dec 2024
2023 -438 -116 -35.8% 01 Jan 2023 31 Dec 2023
2022 -323 -217 -207% 01 Jan 2022 31 Dec 2022
2021 -105 +226 +68.3% 01 Jan 2021 31 Dec 2021
2020 -331 -368 -1008% 01 Jan 2020 31 Dec 2020
2019 36.5 +959 01 Jan 2019 31 Dec 2019
2018 -922 -304 -49.2% 01 Jan 2018 31 Dec 2018
2017 -618 -332 -116% 01 Jan 2017 31 Dec 2017
2016 -286 -78.6 -37.9% 01 Jan 2016 31 Dec 2016
2015 -207 +413 +66.6% 01 Jan 2015 31 Dec 2015
2014 -620 -532 -608% 01 Jan 2014 31 Dec 2014
2013 -87.6 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.